ARYA Sciences Acquisition Corp IV (ARYD)
NASDAQ: ARYD · IEX Real-Time Price · USD
11.31
+0.02 (0.18%)
At close: Apr 16, 2024, 12:00 AM
11.29
-0.02 (-0.18%)
After-hours: Apr 19, 2024, 4:48 PM EDT
Company Description
Arya Sciences Acquisition Corp IV does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.
The company was incorporated in 2020 and is based in New York, New York.
ARYA Sciences Acquisition Corp IV
| Country | United States |
| Founded | 2020 |
| IPO Date | Feb 26, 2021 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 3 |
| CEO | Adam Leo Stone |
Contact Details
Address: 51 Astor Place, 10th Floor New York, New York 10003 United States | |
| Phone | 212-284-2300 |
| Website | perceptivelife.com |
Stock Details
| Ticker Symbol | ARYD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001838821 |
| CUSIP Number | G31659108 |
| ISIN Number | KYG316591083 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Adam Leo Stone | Chief Executive Officer and Director |
| Michael Seth Altman CFA | Chief Financial Officer and Director |
| Konstantin Poukalov | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 2, 2024 | 425 | Filing |
| Apr 2, 2024 | 8-K | Current Report |
| Mar 29, 2024 | 10-K | Annual Report |
| Mar 29, 2024 | 425 | Filing |
| Mar 29, 2024 | 8-K | Current Report |
| Mar 25, 2024 | 425 | Filing |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 28, 2024 | 425 | Filing |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |